PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $875,328 | -2.5% | 396,076 | +12.0% | 0.00% | 0.0% |
Q1 2023 | $897,888 | +22.3% | 353,499 | -10.0% | 0.00% | 0.0% |
Q4 2022 | $734,341 | -7.6% | 392,696 | +26.9% | 0.00% | 0.0% |
Q3 2022 | $795,000 | +248.7% | 309,564 | +161.9% | 0.00% | – |
Q2 2022 | $228,000 | 0.0% | 118,209 | +53.7% | 0.00% | – |
Q1 2022 | $228,000 | +78.1% | 76,931 | +170.8% | 0.00% | – |
Q4 2021 | $128,000 | -52.6% | 28,413 | -48.8% | 0.00% | – |
Q3 2021 | $270,000 | -63.0% | 55,507 | -48.1% | 0.00% | -100.0% |
Q2 2021 | $729,000 | -52.4% | 106,908 | -50.7% | 0.00% | 0.0% |
Q1 2021 | $1,530,000 | -38.2% | 216,653 | -45.2% | 0.00% | -50.0% |
Q4 2020 | $2,477,000 | -25.5% | 395,661 | -35.6% | 0.00% | -33.3% |
Q3 2020 | $3,325,000 | -37.5% | 614,554 | -39.7% | 0.00% | -50.0% |
Q2 2020 | $5,316,000 | +200.8% | 1,018,465 | +81.5% | 0.01% | +100.0% |
Q1 2020 | $1,767,000 | +68.6% | 561,124 | +115.7% | 0.00% | +200.0% |
Q4 2019 | $1,048,000 | +1243.6% | 260,083 | +1343.3% | 0.00% | – |
Q3 2019 | $78,000 | -78.3% | 18,020 | -10.2% | 0.00% | – |
Q4 2017 | $359,000 | +116.3% | 20,071 | +85.7% | 0.00% | – |
Q4 2016 | $166,000 | -40.5% | 10,806 | -49.6% | 0.00% | – |
Q3 2016 | $279,000 | -92.6% | 21,456 | -78.2% | 0.00% | -100.0% |
Q4 2014 | $3,790,000 | – | 98,315 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |